Product Information
DUPIXENT 200 MG/1.14 ML PEN is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $1777.8890 per ML under NDC 00024591902. Its NADAC has been published 110 times since May 22, 2024.
Strength
200 mg/1.14mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024591902
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
DUPILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761055On Market Since
6/14/2021
Pharmacological Classes
Price Statistics
The NADAC for DUPIXENT 200 MG/1.14 ML PEN has been published 110 times since May 22, 2024, and over the history we have for it it has risen 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1777.8890 per ML |
|---|---|
| All-time high | $1779.3726 (Jun 10, 2026) |
| All-time low | $1601.8481 (May 22, 2024) |
| 52-week high | $1779.3726 |
| 52-week low | $1688.5632 |
| Median price | $1688.7966 |
| Average price | $1684.8003 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DUPIXENT 200 MG/1.14 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for DUPIXENT 200 MG/1.14 ML PEN, manufactured by Sanofi-Aventis U.S. LLC, is $1777.8890 per ML (NDC 00024591902), effective Jun 24, 2026.
How has the price of DUPIXENT 200 MG/1.14 ML PEN changed over time?
Over the history we have for it, the NADAC for DUPIXENT 200 MG/1.14 ML PEN has risen 11.0%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for DUPIXENT 200 MG/1.14 ML PEN?
Since May 22, 2024, the NADAC for DUPIXENT 200 MG/1.14 ML PEN has ranged from a low of $1601.8481 (May 22, 2024) to a high of $1779.3726 (Jun 10, 2026), with a median of $1688.7966 per ML.
Are there cheaper alternatives to DUPIXENT 200 MG/1.14 ML PEN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, DUPIXENT 200 MG/1.14 ML SYRING, is $1771.3716 per ML — about 0% below DUPIXENT 200 MG/1.14 ML PEN.
Who manufactures DUPIXENT 200 MG/1.14 ML PEN?
DUPIXENT 200 MG/1.14 ML PEN (NDC 00024591902) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification